ZIMLAB2024-01-012024-03-31 ZIMLAB2024-01-012024-03-31 ZIMLAB2024-01-012024-03-31in-bse-fin:OneOperatingExpenses01Member ZIMLAB2024-01-012024-03-31in-bse-fin:FourOperatingExpenses01Member ZIMLAB2024-03-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 541400 ZIMLAB NA Zim Laboratories Limited Equity 2023-04-01 2024-03-31 2024-05-13 2024-05-06 INR Lakhs Yearly 14:30:00 20:45:00 2024-05-13 2024-05-13 true Cash Flow Indirect Declaration of unmodified opinion Single segment Pharmaceutical Industry 2024-01-01 2024-03-31 Audited Standalone 1173872000.00 15312000.00 1189184000.00 534858000.00 21183000.00 5865000.00 141197000.00 22771000.00 38748000.00 316531000.00 1081153000.00 108031000.00 0.00 108031000.00 -12885000.00 42013000.00 29128000.00 0.00 78903000.00 0.00 0.00 0.00 0.00 78903000.00 -356000.00 78547000.00 78547000.00 0.00 487258000.00 10 1.62 1.62 0.00 0.00 1.62 1.62 0.00 0.03 0.06 Notes (A to C): 1) The above results were reviewed and recommended by the Audit Committee and approved by the Board of Directors at their respective meetings held on 13 May 2024. There are no qualifications in the audit report issued for the year ended 31 March 2024. 2) These financial results have been prepared in accordance with the recognition and measurement principles of applicable Indian Accounting Standard ('Ind AS') notified under the Companies (Indian Accounting Standards) Rules, 2015 (as amended), as prescribed under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations and guidelines issued by the Securities and Exchange Board of India (SEBI). 3) The figures for the quarters ended 31 March 2024 and 31 March 2023 are the balancing figures between the audited figures for the years ended as on that date and the year to date figures upto the end of third quarter of the respective financial years, on which auditors had performed a limited review. 4) The Company is principally engaged in a single business segment which is pharmaceuticals . 5) The Company had entered into an escrow agreement in 2017 (with subsequent renewals) with one of its shareholders, wherein the shareholder had provided his holdings to the extent of 30 Lakhs equity shares (including 25 Lakhs bonus shares) as a security towards realization of covered trade receivables. During the year, the equity shares have been liquidated at a gross consideration of Rs. 3,067.58 lakhs. Accordingly, the net amount realised (which is gross consideration as reduced by the applicable taxes and charges) has been recognised as a credit to the 'Retained Earnings' under 'Other equity' in accordance with the guidance under Ind AS 1- Presentation of Financial Statements, which states that transactions with shareholders (being the owners of Company), shall be recognized under Equity. 6) Figures of previous period/year have been regrouped/rearranged wherever necessary. The impact of the same is not material to the users of financial statement. Place: Nagpur Anwar S. Daud Date: 13 May 2024 Managing Director Single segment 2023-04-01 2024-03-31 Audited Standalone 3654732000.00 46910000.00 3701642000.00 1776983000.00 77961000.00 -140532000.00 508103000.00 69244000.00 148293000.00 1031193000.00 3471245000.00 230397000.00 0.00 230397000.00 8296000.00 54546000.00 62842000.00 0.00 167555000.00 0.00 0.00 0.00 0.00 167555000.00 -3819000.00 163736000.00 163736000.00 0.00 487258000.00 10 1832284000.00 3.44 3.44 0.00 0.00 3.44 3.44 0.00 0.02 0.04 Other Expenses 316531000.00 Other Expenses 1031193000.00 1569189000.00 235160000.00 0.00 0.00 35743000.00 167311000.00 0.00 0.00 82296000.00 0.00 0.00 7830000.00 90126000.00 0.00 150342000.00 2247871000.00 812629000.00 0.00 1000925000.00 1735000.00 5799000.00 0.00 3185000.00 1011644000.00 0.00 352859000.00 2177132000.00 0.00 0.00 4425003000.00 487258000.00 1832284000.00 2319542000.00 2319542000.00 356006000.00 0.00 29495000.00 385501000.00 0.00 101009000.00 0.00 0.00 486510000.00 707520000.00 626646000.00 131069000.00 1465235000.00 145748000.00 7968000.00 0.00 0.00 1618951000.00 0.00 0.00 2105461000.00 4425003000.00 69244000.00 -275567000.00 -115128000.00 0.00 0.00 -4388000.00 -8063000.00 -12165000.00 0.00 33607000.00 0.00 0.00 85644000.00 148293000.00 0.00 0.00 0.00 -7551000.00 0.00 -11398000.00 0.00 318000.00 0.00 0.00 0.00 0.00 9543000.00 -1747000.00 0.00 -89994000.00 140403000.00 0.00 0.00 0.00 25683000.00 0.00 114720000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 692000.00 725931000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 60000.00 322000.00 0.00 5434000.00 0.00 -719423000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 281469000.00 -192222000.00 0.00 17239000.00 0.00 75136000.00 0.00 214024000.00 595340000.00 -9363000.00 0.00 -9363000.00 11098000.00 1735000.00 -503000.00 -5388000.00 -147000.00 -1569000.00 0.00 0.00